行情

NTRA

NTRA

Natera
NASDAQ

实时行情|Nasdaq Last Sale

39.05
+0.86
+2.25%
交易中 15:26 10/15 EDT
开盘
38.23
昨收
38.19
最高
39.53
最低
38.18
成交量
47.25万
成交额
--
52周最高
39.53
52周最低
11.08
市值
27.39亿
市盈率(TTM)
-19.3298
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NTRA 新闻

  • 高盛CEO:Apple Card是"有史以来最成功信用卡发行"
  • 新浪美股.41分钟前
  • 联储贴现率决策内部分歧加剧 对立双方接近"五五开"
  • 新浪美股.43分钟前
  • 巴菲特向美联储寻求批准 将增持美国银行股份超过10%
  • 新浪美股.54分钟前
  • 邓普顿基金明星经理失手 旗舰债基三个月亏30亿美元
  • 新浪美股.1小时前

更多

所属板块

医疗设备、用品及经销
+1.35%
医疗设备和用品
+1.14%

热门股票

名称
价格
涨跌幅

NTRA 简况

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).
展开

Webull提供Natera Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。